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Oxidative stressInterest in organoselenide chemistry and biochemistry has increased in the past three decades, mainly
due to their chemical and biological activities. Here, we investigated the protective effect of the organic
selenium compound diphenyl diselenide (PhSe)2 (5 lmol/kg), in a mouse model of methylmercury
(MeHg)-induced brain toxicity. Our group has previously demonstrated that the oral and repeated
administration (21 days) of MeHg (40 mg/L) induced MeHg brain accumulation at toxic concentrations,
and a pattern of severe cortical and cerebellar biochemical and behavioral. In order to assess neurotox-
icity, the neurochemical parameters, namely, mitochondrial complexes I, II, II–III and IV, glutathione per-
oxidase (GPx) and glutathione reductase (GR) activities, the content of thiobarbituric acid-reactive
substances (TBA-RS), 8-hydroxy-20-deoxyguanosine (8-OHdG), and brain-derived neurotrophic factor
(BDNF), as well as, metal deposition were investigated in mouse cerebral cortex. Cortical neurotoxicity
induced by brain MeHg deposition was characterized by the reduction of complexes I, II, and IV activities,
reduction of GPx and increased GR activities, increased TBA-RS and 8-OHdG content, and reduced BDNF
levels. The daily treatment with (PhSe)2 was able to counteract the inhibitory effect of MeHg on mito-
chondrial activities, the increased oxidative stress parameters, TBA-RS and 8-OHdG levels, and the reduc-
tion of BDNF content. The observed protective (PhSe)2 effect could be linked to its antioxidant properties
and/or its ability to reduce MeHg deposition in brain, which was here histochemically corroborated. Alto-
gether, these data indicate that (PhSe)2 could be consider as a neuroprotectant compound to be tested
under neurotoxicity.
 2013 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Selenium is a fundamental component of the living cells of a
variety of organisms with antioxidant properties [1–5], and it is
necessary for the expression of at least 25 selenium-dependent en-
zymes, including the powerful antioxidant glutathione peroxidase
(GPx), which protects macromolecules from peroxidative damage
[6], the thioredoxin reductase [7] and several other selenoproteins
that modulate the cellular redox and antioxidant status [8,9].
Interest in compounds containing selenium has increased in the
past three decades, mainly due to their biological activities (for arevision see Ref. [4]). The pharmacological properties of organose-
lenium compounds have been extensively reported after the iden-
tiﬁcation of ebselen [2-phenyl-1,2-benzisoselenazole-3 (2H)-one]
as a mimetic of GPx [10]. In this scenario, diphenyl diselenide
(PhSe)2, is the simplest of the synthetic diaryl diselenides, and it
has been reported to possess antioxidant, antinociceptive, antiin-
ﬂammatory, antihyperglycemic, antiatherogenic, hepatoprotective,
antiulcer, antidepressant-like and anxiolytic-like actions [11–19].
The antioxidant activity of (PhSe)2 may be related to its thiol
peroxidase-like activity, where the reaction catalyzed by the orga-
noselenium compound is similar to that catalyzed by the antioxi-
dant enzyme, GPx [4]. This antioxidant property is of particular
signiﬁcance, in living cells, because it decomposes hydrogen perox-
ide, phospholipid hydroperoxide and other organic hydroxyperox-
ides, preventing the formation of reactive and toxic hydroxyl, and
lipoperoxyl radicals [20]. Based on this, it appears that (PhSe)2
could behave as a potent protective compound in models of
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and high content of easily peroxidizable long-chain polyunsatu-
rated fatty acids, which are particularly vulnerable to oxidative
damage [21]. Thus, (PhSe)2 appears to be a promising neuroprotec-
tive agent, based on the potential antioxidant activity, and also, on
its low toxicity, which has been demonstrated in rabbits [22,23]
and rodents [24]. Furthermore, (PhSe)2 is less toxic than the related
compound ebselen [25]. In line with this, ebselen has been already
used in clinical trials and consistently demonstrated to reduce
brain damage in patients with delayed neurological deﬁcits after
aneurysmal subarachnoid hemorrhage, and improved the outcome
of acute ischemic stroke [26–28].
Taking into account the potential pharmacological properties of
organoselenium compounds and the lower toxicity of (PhSe)2,
when compared to ebselen or the inorganic forms of selenium
[2,29], as well as the scarcity of studies on molecular mechanisms
related to (PhSe)2-induced neuroprotection, the present study
aimed to analyze the potential neuroprotective effect of (PhSe)2
on neurochemical parameters in brain from MeHg-poisoned mice.2. Experimental procedures
2.1. Animals and reagents
Male Swiss albino mice of 60 days of life obtained from the Cen-
tral Animal House of the Centre for Biological Sciences, Universid-
ade Federal de Santa Catarina, Florianópolis – SC, Brazil, were used.
The animals were maintained on a 12-h light/dark cycle (lights on
07:00–19:00 h) in a constant temperature (22 ± 1 C) colony room,
with free access to water and protein commercial chow (Nuvital-
PR, Brazil). The experimental protocol was approved by the Ethics
Committee for Animal Research (PP00084/CEUA) of the Universid-
ade Federal de Santa Catarina, Florianópolis – SC, Brazil. The exper-
iments were carried out in accordance with the European
Communities Council Directive of 24 November 1986 (86/609/
EEC). All efforts were made to minimize the number of animals
used and their suffering.
The chemicals were of analytical grade and purchased from Sig-
ma (St. Louis, MO, USA), except methylmercury (II) chloride which
was obtained from Aldrich Chemical Co. (Milwaukee, WI, USA), the
monoclonal antibody against 8-hydroxy-20-deoxyguanosine and
polyclonal antibody against BDNF that were obtained from JaICA
(Fukuroi, Shizuoka, Japan) and Chemicon (Temecula, CA, USA),
respectively, and 3,30-diaminobenzidine from Dako Cytomation
(Glostrup, Denmark). (PhSe)2 was prepared and characterized by
our group as previously described [30]. The chemical purity of
(PhSe)2 was determined by GC/HPLC (99.9% of purity).
The biochemical measurements were performed in a Varian
Cary 50 spectrophotometer (Varian Inc., Palo Alto, CA, USA) with
temperature control. For brain tissue preparations an Eppendorf
5415 R (Eppendorf, Hamburg, Germany) centrifuge was used. The
microscopic analyses were performed with a Nikon microscope
(Nikon, USA).2.2. Treatments
Twenty-four mice were randonly divided into four experimen-
tal groups and received vehicle (controls), MeHg (40 mg/L), (PhSe)2
(5 lmol/kg) and MeHg plus (PhSe)2 during 21 days. Our group has
previously demonstrated that the oral and repeated (21 days)
administration of MeHg 40 mg/L induced MeHg brain accumula-
tion at toxic concentrations of 3–5 lg/g tissue (3–5 ppm) [29,31],
which could be translated into a brain concentration of 15–
30 lM [32]. The toxicant was diluted in tap water, and was freely
available. (PhSe)2 was dissolved on dimethylsulfoxide (DMSO) andsubcutaneously administered [33,34]. Proper control animals re-
ceived vehicle injections (1 mL/kg body weight).
The liquid and solid consumptions did not signiﬁcantly differ
between the groups (data not shown).
In some experiments MeHg (10 and 50 lM) was dissolved in
DMEM, (PhSe)2 (1 lM) in DMSO and exposed to astroglioma C6
cells.
2.3. Tissue preparation
Animals were sacriﬁced by decapitation without anesthesia
24 h after the last subcutaneous administration. The brain was rap-
idly excised on a Petri dish placed on ice and the cerebral cortex
was dissected, weighed and kept chilled until homogenization,
which was performed using a ground glass type Potter-Elvejhem
homogenizer. The maximum period between the tissue prepara-
tion and enzyme analysis was always less than a week.
2.4. Brain preparations for measuring the respiratory chain complex
activities
Mouse cerebral cortex was homogenized in 10 volumes of phos-
phate buffer (pH 7.4), containing 0.3 M sucrose, 5 mMMOPS, 1 mM
EGTA and 0.1% bovine serum albumin. The homogenates were cen-
trifuged at 1500g for 10 min at 4 C and the pellet was discarded.
The supernatant was centrifuged at 17,000g for 10 min at 4 C in
order to isolate the mitochondrial fraction present in the pellet,
which was ﬁnally dissolved in the same buffer [35].
2.5. Brain preparations for measuring the oxidative stress parameters
Brain tissue was homogenized in 5 volumes (1:5, w/v) of 20 mM
sodium phosphate buffer (pH 7.4) containing 140 mM KCl. Homog-
enates were centrifuged at 750g for 10 min at 4 C to discard nuclei
and cell debris [36,37]. The pellet was discarded and the superna-
tant, a suspension of mixed and preserved organelles, including
mitochondria,was separatedand immediatelyused for theanalyses.
2.6. Maintenance and treatment of cell line
The astroglioma C6 cell line was obtained from the American
Type Culture Collection (Rockville, Maryland, USA). The cells were
seeded in ﬂasks and cultured in Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM) (pH 7.4) containing 5% fetal bovine serum, sterile
antimycotic solution 100: penicillin 100 IU/mL, streptomycin
0.1 mg/mL and amphotericin 0.25 lg/mL, in a 95% O2 and 5% CO2
humidiﬁed atmosphere, at 37 C. Exponentially growing cells were
detached from the culture ﬂasks using 0.05% trypsin/ethylene-
diaminetetracetic acid and seeded in 96-well plates (5  104 -
cells/well) [38]. After cells reached conﬂuence, the culture medium
was removed by suction and the cells were exposed to 10 and
50 lMMeHg for 1 h, and the reduction of MTT (for assessing cellu-
lar viability) was used as a neurotoxicity endpoint. In addition,
cells were also exposed to (PhSe)2, before, during or after MeHg
exposure, as follows:
(a) 24 h 1 lM (PhSe)2 (controls).
(b) 24 h 1 lM (PhSe)2 + 1 h 10 or 50 lM MeHg (pre-treatment).
(c) 1 h 1 lM (PhSe)2 + 1 h 10 or 50 lM MeHg (concomitant
exposure).
(d) 1 h 10 or 50 lMMeHg + 24 h 1 lM (PhSe)2 (post-treatment).
2.7. Preparation of mouse cortical slices
Mice were euthanized by decapitation and had their cerebral
cortex dissected on ice in Krebs–Ringer bicarbonate buffer (KRB;
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KH2PO4, 25 mM NaHCO3 and 10 mM D-glucose). The buffer was
bubbled with a mixture of 95% O2 and 5% CO2 up to pH 7.4. Slices
of 400 lm thickness were prepared using a McIlwain tissue chop-
per. The slices were individually pre-incubated with KRB for
30 min at room temperature. Then, the medium of the wells was
changed and the cortical slices were exposed to MeHg.
2.8. Cellular viability assay
MTT (3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide) assaywas used to evaluate cellular viability. Activemitochon-
drial and cytosolic dehydrogenases cleavage and reduce the soluble
yellowMTT dye into the insoluble purple formazan. Cells and slices
were incubated with MeHg and/or (PhSe)2, in a 5% CO2/95% O2,
humidiﬁed atmosphere, at 37 C. At the end of the incubation peri-
od, MTT test were performed. The formazan formationwas spectro-
photometrically assayed at 570 nm [39]. Results are indicated as
percentage of controls, to which 100% activity was attributed.
2.9. Lactate levels measurement
The formation and release of lactate was measured in the super-
natants of cortical slices MeHg-exposed during 1 h at 37 C
through a speciﬁc analyzer (YSI 2700 STAT, Yellow Springs, Ohio,
USA), as previously described by our group [40]. The results were
calculated as mmol/L.
2.10. Determination of hydrogen peroxide (H2O2) generation
H2O2 production was determined as previously reported [41].
The method is based on the formation of a ﬂuorescent dimmer
through the reaction between H2O2 and homovanilic acid, which
are substrates for the enzyme horseradish peroxidase (HRP). Corti-
cal slices were incubated during 1 h at 37 C with MeHg in a solu-
tion containing 137 mM NaCl, 40 mM KCl, 0.25 mM Na2HPO4,
0.44 mM KH2PO4, 1.3 mM CaCl2, 1 mM MgSO4, 4.2 mM NaHCO3.
Afterwards, this medium was removed and 6 U/mL horseradish
peroxidase, 0.1 mM homovanilic acid, 5 mM sodium succinate
and 2 lM rotenone were added to the MeHg-treated cortical slices.
After 15 min of incubation at 37 C the reaction was stopped by
adding 0.1 M glycine solution pH 10, and the ﬂuorescence was
measured by using excitation and emission wavelengths of 321
and 421 nm, respectively. H2O2 production was expressed as per-
centage of controls.
2.11. Measurement of the respiratory chain enzyme activities
Complex I activity was measured by the rate of NADH-depen-
dent ferricyanide reduction at 420 nm (1 mM1cm1) as described
in Cassina and Radi [42]. The activities of succinate-2,6-dichloroin-
dophenol (DCIP)-oxidoreductase (complex II) and succinate:cyto-
chrome c oxidoreductase (complex II-CoQ-complex III) were
determined according to the method describe by Fischer et al.
[43] and that for cytochrome c oxidase (complex IV) activity accord-
ing to Rustin et al. [44]. The methods described to measure these
activities were slightly modiﬁed, as detailed in previous reports
[29,35]. The activities of the respiratory chain complexes were cal-
culated as nmol/min/mg protein. The activities of mitochondrial
complexes were not modiﬁed by the vehicle used (DMSO).
2.12. Measurement of glutathione-related enzymes activities:
glutathione reductase (GR) and glutathione peroxidase (GPx) assays
GR and GPx activities were assessed spectrophotometrically by
monitoring the NADPH disappearance at 340 nm by using oxidizedglutathione and tert-butylhydroperoxide as substrates, respec-
tively, as previously reported with slight modiﬁcations [45–47].
The speciﬁc activity was calculated as units/mg protein. One unit
of GR or GPx is deﬁned as 1 lmol NADPH consumed/min.
2.13. Measurement of thiobarbituric acid-reactive substances (TBA-
RS)
TBA-RS was determined in an acid-heating reaction containing
thiobarbituric acid [48][43]. After incubation in boiling water, the
resulting pink-stained TBA-RS, was determined in a spectropho-
tometer at 532 nm. TBA-RS levels were calculated as nmol/mg pro-
tein, using e = 13,600 M.
2.14. Brain metal deposition
Brain metal (mercury) deposition was assessed by light micros-
copy using the autometallography (AMG) method [49]. Cortical
sections were counterstained with hematoxylin for better visuali-
zation. Mice were anesthetized with ketamine (55 mg/kg) and
xylazine (11 mg/kg) and transcardially perfused with heparin
(1000 U/mL) in physiological saline (NaCl, 0.9%) followed by 4%
paraformaldehyde in physiological saline 24 h hours after the last
injection. Afterwards, the brain was immersed in the ﬁxative Car-
noy’s solution, dehydrated in ethanol, embedded in parafﬁn, and
sectioned in 30 lm slices. Metal deposition was visualized by the
presence of brown granules, which represents aggregated silver
surrounding the deposited metal. To determine the percentage of
AMG labeled cells, stereological analysis of brain was performed
with an Nikon microscope (1000) using a Weibel graticule eye-
piece (Weibel Graticule n2, Tonbridge Kent, England) in twenty
random visual ﬁelds in each histological section [50]. The measure-
ments were done by an investigator who was blind to the treat-
ment assignments, and the all cortical layers, including the
occipital cortex were taken for the measurements.
2.15. 8-Hydroxy-20-deoxyguanosine and brain-derived neurotrophic
factor (BDNF) immunohistochemistry
The cortical tissue sectioned in 7 lm slices was further pro-
cessed for quenching the endogenous peroxidase by using 1.5%
hydrogen peroxide in methanol (v/v) for 20 min. A high tempera-
ture antigen retrieval was performed by immersion of the slides
in a water bath at 95–98 C in 10 mM trisodium citrate buffer
(pH 6.0), for 45 min. Immunohistochemistry was performed to
identify DNA damage and neutrophin content by using the primary
monoclonal antibody anti-8-hydroxy-20-deoxyguanosine (dilution,
1:100), and the polyclonal antibody anti-BDNF (dilution, 1:1000).
Slices were incubated overnight and were followed by washes with
PBS. After incubation with appropriate biotinylated secondary
antibodies and incubated with streptavidin–biotin–peroxidase,
the sections were developed with 3,30-diaminobenzidine in chro-
mogen solution and counterstained with Harris’s hematoxylin.
Control and experimental tissues were placed on the same slide
and processed under the same conditions. The immunostaining
was assessed in ﬁve layers of cortex. Images of stained cortex (I,
II, III, IV and V layer) were acquired using a Sight DS-5M-L1 digital
camera (Nikon, Melville, NY, USA) connected to an Eclipse 50i light
microscope (Nikon) at 100 and 1000 magniﬁcation. A threshold
for the optical density that better discriminated staining from the
background was obtained using the NIH ImageJ 1.36b imaging
software (NIH, Bethesda, MD, USA). Five to eight images per section
were captured. The measurements were done by an investigator
who was blind to the treatment assignments, and the all cortical
layers, including the occipital cortex were taken for the measure-
ments. For relative quantiﬁcation of immunoreactivity, total pixels
Fig. 1. Metal deposition in the cerebral cortex from adult mice exposed (21 days) to methylmercury (MeHg; 40 mg/L) and/or diphenyl diselenide (PhSe)2; 5 lmol/kg). Cortical
sections were counterstained with hematoxylin for better visualization. Mercury deposition was visualized by the presence of brown granules, which represents aggregated
silver surrounding the deposited metal (arrows). Percentage of positive cells for autometallography methodology is expressed as mean ± S.E.M. ⁄⁄P < 0.01, vs. controls;
#P < 0.05, vs. MeHg (One-way ANOVA followed by the Tukey test). A: Controls; B, (PhSe)2; C, MeHg; D, MeHg plus (PhSe)2; E, percentage of positive cells for autometallography
methodology.
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optical density (O.D.).2.16. Protein determination
Homogenate and mitochondrial preparation protein content
was determined by the method of Bradford et al. [51] using bovine
serum albumin as standard.Fig. 2. Activities of the respiratory chain complexes I (A), II (B), II–III (C) and IV (D) a
glutathione reductase (GR; F) activities and thiobarbituric acid-reactive substances (TBA-
(21 days) to methylmercury (MeHg; 40 mg/L) and/or diphenyl diselenide ((PhSe)2; 5 l
⁄⁄⁄P < 0.001, vs. controls and ##P < 0.01, ###P < 0.001, vs. MeHg group (One-way ANOVA2.17. Statistical analysis
Results are presented as mean ± SEM. Assays were performed in
triplicate. Data were analyzed using one-way ANOVA followed by
the post hoc of Tukey test when F was signiﬁcant. Only signiﬁcant
F values are given in the text. Differences between the groups were
rated signiﬁcant at P < 0.05. All analyses were carried out in an
IBM-compatible PC computer using the Statistical Package for the
Social Sciences (SPSS) software.nd the oxidative stress parameters, namely glutathione peroxidase (GPx; E) and
RS; G) measurement in cortical mitochondrial preparations from adult mice exposed
mol/kg). Values are mean ± S.E.M. from four to six animals. ⁄P < 0.05, ⁄⁄P < 0.01,
followed by the Tukey test).
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Our group has previously demonstrated that the repeated expo-
sure to MeHg (40 mg/L in tap water) provokes the accumulation of
mercury in the brain at toxic concentrations [29,31]. As shown in
Fig. 1, the evident deposition of mercury in all cortical layers of ani-
mals receiving MeHg was signiﬁcantly prevented by the co-admin-
istration of (PhSe)2 [F(3,8) = 8.72; P < 0.01]. This protective effect of
(PhSe)2 was also observed in the MeHg-induced mitochondrial
dysfunction. Fig. 2 shows that the co-exposure, MeHg plus (PhSe)2,
signiﬁcantly attenuated the MeHg-inhibitory effect on the activi-
ties of the complexes I–IV of the respiratory chain [complex I:
F(3,17) = 48.70; P < 0.0001; complex II: F(3,16) = 6.53; P < 0.01; com-
plex II to III: F(3,12) = 9.13; P < 0.01; complex IV: F(3,14) = 5.73;
P < 0.01] (Fig. 2A–D). To further understand, if the effects of diphe-
nyl diselenide against MeHg-induced cytotoxicity are dependent
on whether the exposure of both compounds is concomitant or
not, astroglioma C6 cells were treated with MeHg and pre-, post-
or co-exposed to the calchogen. Fig. 3A shows that 24 h of expo-
sure to 1 lM (PhSe)2 or 1 h to 10 lM MeHg did not compromiseFig. 3. Mitochondrial activity in astroglioma C6 cells exposed to methylmercury (MeHg;
mean ± S.E.M. from ﬁve to six independent experiments. ⁄⁄⁄P < 0.001, vs. controls and #P <
ANOVA followed by the Tukey test).cell viability; however, 50 lM MeHg signiﬁcantly reduced (up to
60%) this measurement [F(8,37) = 31.22; P < 0.001]. In addition, the
co-incubation for 1 h did not avoid the reduced cell viability in-
duced by 50 lM MeHg; however, (PhSe)2 pre- (up to 30%) or
post-incubation (up to 66%) signiﬁcantly attenuated this effect.
Furthermore, in order to link the observed MeHg-provoked cell
reduced viability with impairment of mitochondrial oxidative
metabolism, lactate and H2O2 production, two parameters inti-
mately linked to dysfunctional mitochondria, were measure in par-
allel to MTT reduction in mouse cortical slices. Fig. 3B–D show that
MTT reduction was diminished [t(2 pairs) = 5.38; P < 0.05], while lac-
tate release [F(2,9) = 14.29; P < 0.01] and H2O2 generation (driven by
rotenone plus succinate addition) [F(2,12) = 8.41; P < 0.01] were in-
creased after the exposure (1 h) of mouse cortical slices to
50 mM MeHg.
(PhSe)2 also showed antioxidant activities in the brain of poi-
soned animals. Fig. 2G shows that (PhSe)2 treatment completely
prevented the MeHg-induced lipid peroxidation, and also inhibited
the spontaneous lipid oxidation seen in brain control animals
[F(3,18) = 38.41; P < 0.0001]. In addition, Fig. 4(A–E) shows that the10 and 50 lM; 1 h) and/or diphenyl diselenide ((PhSe)2; 1 lM; 1 or 24 h). Values are
0.05, ###P < 0.001, vs. 50 lMMeHg; only relevant comparisons are shown (One-way
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OHdG in cerebral cortex of mice receiving MeHg (Fig. 4C, mainly in
cortical layer II), was signiﬁcantly prevented by the selenium com-
pound [F(3,146) = 5.09; P < 0.01] (Fig. 4E). However, GPx and GR
activities alterations caused by MeHg were not prevented by the
use of (PhSe)2 (GPx activity: [F(3,18) = 6.70; P < 0.01]; GR activity:
[F(3,19) = 13.04; P < 0.0001]) (Fig. 2E and F).
Finally, Fig. 5B shows that the content of the neurotrophic brain
factor, BDNF, was signiﬁcantly reduced in cerebral cortex (mainly
in cortical layer II) of animals exposed to oral MeHg. This neutorox-
ic effect elicited by the mercurial was attenuated by (PhSe)2
administration [F(3,72) = 3.72; P < 0.05].
4. Discussion
The search for new drugs capable of affecting the pathologies
related to oxidative stress has gained momentum over the years,
resulting in numerous reports on signiﬁcant activities of natural
or synthetic antioxidant agents [52]. (PhSe)2 is considered a poten-
tial antioxidant compound and it has been successfully employed
for protection in models of hypercholesterolemia [53], diabetes
[12,54], LDL oxidation [15], pain (nociception) [18], antiulcer and
inﬂammation [11,19], hepatotoxicity [16], toxicity induced by
metals [5], depression and anxiety [17]. These properties appear
to be due to the presence of selenium atoms and GPx mimetic
activity, which are the characteristics of enzymes that control cel-
lular redox and antioxidant status, including GPx and TrxRs [8,9].
Here, it was demonstrated for the ﬁrst time that (PhSe)2 be-
haves also as a potent neuroprotective agent by avoiding mito-
chondrial dysfunction (Fig. 2), in a model of severe neurototixicy
induced by MeHg exposure. The poisoning induced by MeHg has
been associated with degeneration of the cerebellar granule cell
layer and the calcarine region of the occipital cortex in humans
[55–58], as well as rodent brains [59]. The additional neuroprotec-
tion afforded by (PhSe)2 in cerebral cortex of MeHg-exposed mice
was related to the attenuation of oxidative stress (Figs. 2–4), and
reduced BDNF content counterbalancing.Fig. 4. Immunohistochemistry for 8-hydroxy-20-deoxyguanosine (8-OHdG) in brain from
diselenide ((PhSe)2; 5 lmol/kg). For relative quantiﬁcation of immunoreactivity agai
mean ± S.E.M. of optical density (O.D.). ⁄⁄P < 0.01, vs. controls; ##P < 0.01, vs. MeHg (One-
plus (PhSe)2; E, Quantiﬁcation of 8-OHdG immunoreactivity in treated mice. Bars represThe protective activity of this structurally simple organosele-
nium compound could be linked to the (PhSe)2-elicited reduction
of brain metal deposition (Fig. 1), effect that has already been dem-
onstrated by our group, in central and also peripheral tissues [5].
Mechanistically, (PhSe)2, due to the intrinsic thiol–peroxidase like
activity, could mediate its own reduction to form a selenol inter-
mediate (reduced form; PhSeH), which can react with strong afﬁn-
ity with the electrophile MeHg (Fig. 6) [60–62]. After the reaction
between PhSeH and MeHg, a stable PhSe–HgCH3 complex might
be formed in the periphery, brain and, consequently, it may reduce
the cellular availability of MeHg, and therefore, the linked-mecha-
nism of neurotoxicity [60–62]. Furthermore, this complex could be
more easily excreted than complexes of MeHg with endogenous
thiolates [5], and/or be less transported into the brain than com-
plexes with cysteine [5,63–65]. Additionally, the yielded protection
can also be associated with the formation of a selenol intermediate,
selenophenol (Fig. 6) and by hepatic or cerebral TrxRs, which could
consequently decompose hydrogen peroxide, peroxynitrite and li-
pid peroxides [4,5,15].
Besides the potential (PhSe)2 ability of quenching the neurotox-
icant, and its antioxidant activity, it appears to be a promising neu-
roprotective molecule. In this context, the molecule displays very
low toxicological activity, that has been already demonstrated in
rabbits [22,23] and rodents [24]. Our group and others have shown
that repeated administration of 5 lmol/kg (PhSe)2 did not change
liver, kidney, brain or spleen toxicological parameters in those ani-
mal models [22–25,66]. Moreover, (PhSe)2 is less toxic than the re-
lated compound ebselen, which has been already used in clinical
trials and consistently demonstrated to reduce brain damage, in
patients with delayed neurological deﬁcits after aneurysmal sub-
arachnoid hemorrhage, and improved the outcome of acute ische-
mic stroke [25–28]. Additionally, our group previously showed
that the inorganic selenium compound, sodium selenite (Na2SeO3),
efﬁciently prevented from some cortical MeHg-induced mitochon-
drial alterations and mercury deposition. Nevertheless, it did not
prevent from MeHg-induced oxidative stress, and in some condi-
tions, Na2SeO3 was as hazardous as the mercurial [29].adult mice exposed (21 days) to methylmercury (MeHg; 40 mg/L) and/or diphenyl
nst 8-OHdG, total pixels intensity was determined and data were expressed as
way ANOVA followed by the Tukey test). A, Controls; B, (PhSe)2; C, MeHg; D, MeHg
ent 10 lm.
Fig. 5. Immunohistochemistry for brain-derived neurotrophic factor (BDNF) in brain from adult mice exposed (21 days) methylmercury (MeHg; 40 mg/L) and/or diphenyl
diselenide ((PhSe)2; 5 lmol/kg). For relative quantiﬁcation of immunoreactivity against BDNF, total pixels intensity was determined and data were expressed as
mean ± S.E.M. of optical density (O.D.). ⁄P < 0.05, vs. controls (One-way ANOVA followed by the Tukey test). A, Controls; B, (PhSe)2; C, MeHg; D, MeHg plus (PhSe)2; E,
quantiﬁcation of BDNF immunoreactivity in treated mice. Bars represent 10 lm.
Fig. 6. Scheme of (PhSe)2 antioxidant pathways in peripheral and brain tissues. (PhSe)2 can be transformed to its selenol or selenolate intermediate (PhSeH/PhSe) either by
interacting directly with endogenous thiol groups (RSH; pathway 1) or via the enzymatic reduction of (PhSe)2 by thioredoxin reductase (TrxR; pathway 2); [55–57]. The PhSe
intermediate might demonstrate antioxidant activity against methylmercury (MeHg) either via decomposition of peroxides (which is an important pro-oxidant in MeHg
poisoning [69,70], or via formation of an inert and/or more excretable complex [5]).
24 V. Glaser et al. / Chemico-Biological Interactions 206 (2013) 18–26As previously mentioned, (PhSe)2 appears to be less toxic than
the known antioxidant ebselen, or selenium-related inorganic
compounds [2], giving new therapeutical opportunities in neuro-
toxicity and neurodegenerative conditions. In this scenario, (PhSe)2
also prevented from MeHg-induced BDNF reduction and DNA oxi-
dation, protecting therefore from cell death. This could involve the
mitoprotective effect demonstrated in the prevention of complexes
inhibition I-IV elicited by MeHg, since mitochondria are the key
players in ATP production and diverse cell signaling events that
are essential for eukaryotic cells survival (for a revision see Ref.
[67]). In addition, the positive effect of (PhSe)2 to mitochondria
could also be linked to the capacity of the compound to buffer pro-
tein-linked and free thiol groups, and/or to scavenge ROS. Thus, the
compound could protect the biological activity of the respiratorychain complex enzymes, that are mitochondrial proteins with high
quantity of thiolic residues very sensitive targets of MeHg, by sta-
bilizing the enzyme redox states, by increasing glutathione levels,
or the expression of glutathione synthesizing enzymes or by main-
taining the appropriate redox status of ubiquinone pool linked to
complexes II–III [29,68,69]. In line with this, Bem et al. (2013)
demonstrated that bovine aortic endothelial cells exposed to
(PhSe)2 resulted in a dose-dependent manner increased glutathi-
one concentration, being more effective that ebselen [68]. This
points out to the ability of (PhSe)2 to trigger intracellular mecha-
nisms linked to the activation of the transcription factor Nrf-2 as
previously proposed [68]. This will promote mitochondrial biogen-
esis and increased antioxidant status, and therefore, cellular sur-
vival, even when the antioxidant is added after the cell has been
V. Glaser et al. / Chemico-Biological Interactions 206 (2013) 18–26 25poisoned (Fig. 3A). Furthermore, it is also feasible that the mito-
chondrial metabolism impairment-induced increased anaerobic
glycolysis and oxygen reactive species formation [70] (possibly at
complex II-CoQ-III) will reduce cell viability, effect that could be
rescue by (PhSe)2 treatment.
Moreover, the mitoprotective effect of (PhSe)2 was demon-
strated here in an experimental model where the toxicant prefer-
entially accumulates inside mitochondria, and where brain
mitochondria appear to be more susceptible to MeHg-induced oxi-
dative changes than the liver mitochondria [71,72]. Thereby,
(PhSe)2 could also reduce the mitochondrial incorporation of MeHg
and, consequently, counterbalance mitochondrial toxicity.
In summary, we have demonstrated that the organoselenium
compound, (PhSe)2, is a potent neuroprotective agent for prevent-
ing MeHg-induced brain poisoning, and probably other neurotoxic
and neurodegenerative conditions, mainly based on its capacity to
quench MeHg protecting cells from mitochondrial dysfunction.
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